» Articles » PMID: 24162118

Serial Lobar Lung Lavage in Pulmonary Alveolar Proteinosis

Overview
Date 2013 Oct 29
PMID 24162118
Citations 7
Authors
Affiliations
Soon will be listed here.
Abstract

Pulmonary alveolar proteinosis (PAP) is a rare disease with worldwide distribution and an estimated incidence of 0.36 cases per million. We report a case of a PAP coexisting with Pneumocystis jiroveci pneumonia and Mycobacterium tuberculosis infection. The patient was treated with serial lobar lung lavages, GM-CSF, cotrimoxazole, and antituberculosis drugs. His PaO2 on room air improved from 45.7 to 63.8 torr and pulmonary functions normalized (FVC 81.2%, FEV1 95.3%, FEV1/FVC 91.8). A high-resolution computed tomography scan of the thorax showed clearing of both lower lobes. Whole-lung lavage is used in the treatment of PAP, but it may worsen the hypoxemia and lead to hemodynamic instability during the procedure. To the best of our knowledge, there are no reports of bronchoscopic serial lobar lung lavages in cases of PAP performed in India. This method can be performed in bronchoscopic suites having general anesthesia facilities without the requirement of special gadgets.

Citing Articles

How We Do It: Whole Lung Lavage.

Shrestha D, Dhooria S, Munirathinam G, Sehgal I, Prasad K, Ram B Sarcoidosis Vasc Diffuse Lung Dis. 2022; 39(2):e2022017.

PMID: 36118542 PMC: 9437756. DOI: 10.36141/svdld.v39i2.12884.


A case of autoimmune pulmonary alveolar proteinosis with severe respiratory failure treated with segmental lung lavage and oral statin therapy.

Takano T, Takeda K, Nakamura S, Akiyama G, Ando N, Komori M Respir Med Case Rep. 2022; 38:101684.

PMID: 35707405 PMC: 9190053. DOI: 10.1016/j.rmcr.2022.101684.


Pulmonary Alveolar Proteinosis with Severe Respiratory Failure Improved by Segmental Lung Lavage with Fiberoptic Bronchoscopy under General Anesthesia.

Matsumoto Y, Masuda T, Takahashi T, Hashimoto K, Yamaguchi K, Sakamoto S Intern Med. 2021; 61(3):389-393.

PMID: 34373375 PMC: 8866800. DOI: 10.2169/internalmedicine.7432-21.


Combined-modality therapy for pulmonary alveolar proteinosis in a remote setting: a case report.

Boyce D, Lee J, Shah P, Freeman J, Aboudara M, Hostler D BMC Pulm Med. 2019; 19(1):61.

PMID: 30866900 PMC: 6417025. DOI: 10.1186/s12890-019-0822-x.


Pulmonary alveolar proteinosis: Experience from a tertiary care center and systematic review of Indian literature.

Hadda V, Tiwari P, Madan K, Mohan A, Gupta N, Bharti S Lung India. 2016; 33(6):626-634.

PMID: 27890991 PMC: 5112819. DOI: 10.4103/0970-2113.192876.